318 results
D
SEEL
Seelos Therapeutics Inc
14 Feb 24
Exempt offering of security
4:50pm
, States cannot
routinely require offering materials under this undertaking or otherwise and can require offering materials only to the
extent NSMIA permits them to do so under NSMIA's preservation of their anti-fraud authority.
8-K
EX-10.1
upmh9dy795tgl1bqenq1
30 Jan 24
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-10.2
2mb656v5
30 Jan 24
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-1.1
bv1wnzgk
30 Nov 23
Seelos Therapeutics Announces Pricing of $5.55 Million Public Offering
4:59pm
424B5
4qu47 f9gaoenq
30 Nov 23
Prospectus supplement for primary offering
4:58pm
424B5
kl6kljq eu2pb5
28 Nov 23
Prospectus supplement for primary offering
4:06pm
8-K
EX-10.1
gn6e51 vnmy1ctc5c
25 Sep 23
Entry into a Material Definitive Agreement
4:06pm
424B5
qjzhck l2pelecehggr6
25 Sep 23
Prospectus supplement for primary offering
6:02am